CoChat

Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence

Open access
Sherratt, Samuel C.R., Lero, Michael, Mason, R. Preston · 2020 · Current Opinion in Lipidology

The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.

Abstract

PURPOSE OF REVIEW: The purpose of this review is to assess whether dietary fish oil supplements can be appropriate for patients with elevated triglycerides and cardiovascular risk based on a comprehensive analysis of their composition, and level of regulatory oversight. RECENT FINDINGS: Approximately 19 million people in the United States take fish oil supplements, many for the purpose of treating or preventing heart disease. Unlike prescription products, fish oil supplements are classified as food by the Food and Drug Administration (FDA) and are not required to undergo manufacturing oversight or clinical testing. Analysis of widely used dietary fish oil supplements show that they may have lower amounts of ω-3 than advertised as well as significant levels of saturated fat and oxidized oils which actually may contribute to dyslipidemia. Clinical outcome trials have failed to show a consistent cardiovascular benefit with fish oil supplements and other low-dose mixed ω-3 fatty acids. SUMMARY: In light of limited regulatory oversight and evidence of quality concerns, dietary fish oil supplements are not an appropriate substitute for FDA approved prescription ω-3 fatty acids for their indicated use in treatment of elevated triglycerides or the prevention of cardiovascular events.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mol.0000000000000665

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Box 1 no caption available
Box 1 no caption availableCC BY-NC-ND · PubMed Central
FIGURE 1 Summary of fatty acid content in three leading (by sales) fish oil supplements in the United States (a) and summary of oxidation (TOTOX) products in three leading (by sales) fish oil supplements from the United States (b). The international threshold for TOTOX levels in supplements is 26. Results show as percentage change versus the threshold for TOTOX values in three leading fish oil supplements following normalization to 1 g total ω-3 fatty acid. There was no evidence of significant oxidation in the prescription product analyzed (data not shown). Data taken from [11].
FIGURE 1 Summary of fatty acid content in three leading (by sales) fish oil supplements in the United States (a) and summary of oxidation (TOTOX) products in three leading (by sales) fish oil supplements from the United States (b). The international threshold for TOTOX levels in supplements is 26. Results show as percentage change versus the threshold for TOTOX values in three leading fish oil supplements following normalization to 1 g total ω-3 fatty acid. There was no evidence of significant oxidation in the prescription product analyzed (data not shown). Data taken from [11].CC BY-NC-ND · PubMed Central
FIGURE 2 Summary of risks associated with ingestion of oxidized oils, including oxidized oils sourced from fish.
FIGURE 2 Summary of risks associated with ingestion of oxidized oils, including oxidized oils sourced from fish.CC BY-NC-ND · PubMed Central
FIGURE 3 Overview of fish oil supplement classification and content.
FIGURE 3 Overview of fish oil supplement classification and content.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 1

  1. Frankel EN Lipid oxidation. Bridgwater, UK: The Oily Press; 2005.

Cited by

See all 35

Metadata

Authors
Sherratt, S. C. R., Lero, M., & Mason, R. P.
Affiliations
  • Elucida Research LLC, Beverly, MA, USA
  • University of Massachusetts Chan Medical School (US)
  • Brigham and Women's Hospital (US)
Corresponding author
Mason, R. Preston
Venue
Current Opinion in Lipidology
Published
2020-04
Volume
31
Issue
2
Pages
94-100
ISSN
  • 0957-9672 (ISSN-L)
  • 1473-6535
OpenAlex
W3005213123
Cited by
33
References
62
Citations by year
2026: 1 · 2025: 5 · 2024: 5 · 2023: 3 · 2022: 8 · 2021: 6 · 2020: 5
FWCI
0.67
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Lipidology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords
fish oil supplements, dyslipidemia, triglyceride elevation, omega-3 fatty acids, cardiovascular risk, supplement quality, regulatory oversight, saturated fat, oxidized oil, cardiovascular benefits
MeSH terms
Animals, Cardiovascular Diseases, Fish Oils, Humans, United States, Fatty Acids, Omega-3, Dietary Supplements, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence. https://app.cochat.ai/papers/10.1097/mol.0000000000000665
The paper
Sherratt, S. C. R., Lero, M., & Mason, R. P. (2020). Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence. Current Opinion in Lipidology. https://doi.org/10.1097/mol.0000000000000665

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.